Nexium-Style Products Encourage Price Competition, FDA’s McClellan Says

The availability of follow-on products like AstraZeneca's Nexium can encourage price competition within a therapeutic class, FDA Commissioner McClellan told the National Press Club Aug. 8 in Washington, D.C